Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2022-07-08 M&A Activity
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
UPDATE PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity Classification · 95% confidence The document is an announcement made pursuant to Rule 3.7 of the Hong Kong Code on Takeovers and Mergers (Takeovers Code). It provides an update on the status of potential transactions (likely a takeover or merger) involving Yankuang Energy Group Company Limited. The announcement clarifies that no firm decision has been made yet and that further announcements will be made as progress occurs. It contains disclaimers about the uncertainty of the transactions and advises caution to investors. There are references to previous announcements and regulatory compliance but no detailed financial data, no full report, and no voting results. The document is clearly an update related to a potential merger or acquisition but does not constitute the actual merger filing or tender offer documents. It is an announcement about the progress of a potential M&A transaction. Therefore, the most appropriate classification is M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2022-07-08 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-07-07 English
THIRD ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under the Hong Kong Stock Exchange rules. It concerns a general mandate granted to the board to repurchase H shares and provides instructions to creditors on how to claim their rights. The document is titled as an "Overseas Regulatory Announcement" and is primarily a notification to creditors regarding the share repurchase mandate and related creditor claims. It does not contain financial statements, detailed financial performance, or management discussion and analysis. It is not a report itself but an official announcement related to regulatory compliance and shareholder matters. The content fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-07 English
UPDATE PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity Classification · 95% confidence The document is an announcement made pursuant to Rule 3.7 of the Hong Kong Code on Takeovers and Mergers (Takeovers Code). It provides an update on the status of potential transactions (likely a takeover or merger) involving Yankuang Energy Group Company Limited. The announcement clarifies that no firm decision has been made yet and that further announcements will be made as progress occurs. It contains disclaimers about the uncertainty of the transactions and advises caution to investors. There are references to previous announcements and regulatory compliance but no detailed financial data, no full report, and no voting results. The content is consistent with an update related to merger or takeover activity but is not a full merger filing or tender offer document. It is an announcement updating shareholders and the market on the status of potential M&A activity under the Takeovers Code. Therefore, the most appropriate classification is "M&A Activity (TAR)" which covers announcements and documents related to merger proposals or takeover bids.
2022-07-07 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Major Shareholding Notification Classification · 95% confidence The document is a Public Disclosure Form dated 7 July 2022, detailing dealings in shares of Yankuang Energy Group Company Limited. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is related to disclosures of securities dealings by an exempt principal trader connected with an offeror. The content focuses on share transactions and derivative contracts, not on financial results, management changes, or regulatory filings. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or related securities dealings.
2022-07-07 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 100% confidence The document is a Public Disclosure Form dated 7 July 2022, detailing dealings in shares of Yankuang Energy Group Company Limited. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is related to insider or connected party share transactions. The content focuses on the disclosure of securities dealings by an exempt principal trader connected with the Offeror. There is no indication of financial statements, management discussion, or report publication. The document is a notification of personal share transactions by company directors or connected parties, fitting the definition of Director's Dealing filings.
2022-07-07 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.